These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24790992)

  • 1. Association between ε2/3/4, promoter polymorphism (-491A/T, -427T/C, and -219T/G) at the apolipoprotein E gene, and mental retardation in children from an iodine deficiency area, China.
    Li J; Zhang F; Wang Y; Wang Y; Qin W; Xing Q; Qian X; Guo T; Gao X; He L; Gao J
    Biomed Res Int; 2014; 2014():236702. PubMed ID: 24790992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.
    Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H
    Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
    Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
    Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults.
    Viiri LE; Raitakari OT; Huhtala H; Kähönen M; Rontu R; Juonala M; Hutri-Kähönen N; Marniemi J; Viikari JS; Karhunen PJ; Lehtimäki T
    J Lipid Res; 2006 Jun; 47(6):1298-306. PubMed ID: 16528057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE genotype-function relationship: evidence of -491 A/T promoter polymorphism modifying transcription control but not type 2 diabetes risk.
    Geng H; Law PP; Ng MC; Li T; Liang LY; Ge TF; Wong KB; Liang C; Ma RC; So WY; Chan JC; Ho YY
    PLoS One; 2011; 6(10):e24669. PubMed ID: 22028770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations.
    Viiri LE; Loimaala A; Nenonen A; Islam S; Vuori I; Karhunen PJ; Lehtimäki T
    Atherosclerosis; 2005 Mar; 179(1):161-7. PubMed ID: 15721023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein E promoter polymorphisms with bone structural traits is modified by dietary saturated fat intake - the Cardiovascular Risk in Young Finns study.
    Tolonen S; Mikkilä V; Laaksonen M; Sievänen H; Mononen N; Hernesniemi J; Vehkalahti K; Viikari J; Raitakari O; Kähönen M; Lehtimäki T
    Bone; 2011 May; 48(5):1058-65. PubMed ID: 21266206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
    Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity.
    Parfenov MG; Nikolaeva TY; Sudomoina MA; Fedorova SA; Guekht AB; Gusev EI; Favorova OO
    J Neurol Sci; 2007 Apr; 255(1-2):42-9. PubMed ID: 17328917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY; Ding JQ; Chen SD
    J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
    Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
    Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
    Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
    Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
    Wu H; Huang Q; Yu Z; Wu H; Zhong Z
    Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.